Skip to main content
Elsevier
View Cart

The Resistance of Cervical Cancer to Chemotherapy and its Reversal

  • 1st Edition, Volume 9 - March 20, 2026
  • Latest edition
  • Editor: S. Muthusami
  • Language: English

The Resistance of Cervical Cancer to Chemotherapy and its Reversal provides a holistic understanding of cervical cancer development, immune-evading mechanisms of HPV, immunothe… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Explore resources

Description

The Resistance of Cervical Cancer to Chemotherapy and its Reversal provides a holistic understanding of cervical cancer development, immune-evading mechanisms of HPV, immunotherapies available, methods to study cervical cancer and the development of newer drugs. Content shows the involvement of signaling pathways during chemoresistance in cervical cancer, the involvement of genes in drug resistance, and introduces long noncoding RNAs as novel biomarkers.

In 10 chapters, this book first provides an introduction and history of cervical cancer; next, it discusses the influence of viruses on cervical cancer and finally, it describes therapies to overcome chemotherapy resistance in cervical cancer. This is the perfect reference to provide the fundamental base of knowledge needed for oncologists, pharmacologists, translational investigators, immunotherapists, scientists, and clinicians interested in building a comprehensive understanding of the field.

Key features

  • Focuses on the aspects of cervical cancer resistance towards therapies such as chemoresistance and radioresistance
  • Discusses the sensitizing agents that are being developed for the improvement of current therapies and better management of cervical cancer
  • Identifies the molecular mechanism of HPV integration and cervical cancer development

Readership

cancer researchers, medical oncologists, clinicians, pharmacologists, translational investigators, immunologists, immunotherapists, scientists and clinicals interested in allogeneic adoptive cell therapy, medical students, translational research students, academic institution libraries

Table of contents

1. Wnt signalling and cervical cancer

2. Pharmacologial targets of cervical cancer

3. PD-1, HPV and cervical cancer

4. Radiotherapy and cervical cancer

5. HPV and cervical cancer

6. EGFR and cervical cancer

7. Protein engineering for cervical cancer

8. Anti-virals and cervical cancer

9. Advances in cytological screening for cervical cancer

10. microRNA and cervical cancer

11. Computer aided drug designing for cervical cancer

12. Nanoparticles for the treatment of cervical cancer

Product details

  • Edition: 1
  • Latest edition
  • Volume: 9
  • Published: March 20, 2026
  • Language: English

About the editor

SM

S. Muthusami

Dr. Sridhar Muthusami completed his Ph.D in endocrinology in the year 2011 from the University of Madras, India. His doctoral study was aimed at delineating the molecular mechanism underlying the anabolic actions of Cissus quadrangularis, an indigenous herb believed to exert anabolic effects on bone cells through IGFR. After completing his Ph.D, he has joined for his Postdoctoral work in the department of Radiation Oncology, Chungbuk National University, South Korea. He has worked on the role of Epidermal growth factor/receptor (EGF/EGFR) signaling and its regulation of oncoprotein Fused Toes Homolog (FTS) in cervical cancer cells from 2011 to 2014. He is also involved in the identifying the role of T0070907/EGCG/cordycepin on cervical cancer cells. Since 2015, he moved to the department of biochemistry, Karpagam Academy of Higher Education (Deemed to be University) and serving as Associate Professor and Head at Cancer Research Centre working in the area of development of EGFR TKIs for the treatment/management of cervical cancer/pancreatic cancer.
Affiliations and expertise
Associate Professor and Head, Cancer Research Centre, Karpagam Academy of Higher Education, Coimbatore, India

View book on ScienceDirect

Read The Resistance of Cervical Cancer to Chemotherapy and its Reversal on ScienceDirect